You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

aflibercept

Showing 26 - 50 of 125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular Age-related Macular Degeneration Trial (dose 1 IBI302, Aflibercept, dose 2 IBI302)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • dose 1 IBI302
  • +2 more
  • (no location specified)
May 26, 2022

Anti-VEGF in Real-world

Recruiting
  • Neovascular Age-related Macular Edema
  • +5 more
  • Beijing, Beijing, China
    Wen-Bin Wei
Feb 2, 2022

Colorectal Tumors Trial in France (aflibercept, LV5FU2)

Completed
  • Colorectal Neoplasms
  • Aix En Provence, France
  • +57 more
Mar 23, 2022

Diabetes, Diabetic Retinopathy, Diabetic Macular Edema Trial in Worldwide (THR-687 dose level 1, THR-687 dose level 2, THR-687

Terminated
  • Diabetes Mellitus
  • +2 more
  • THR-687 dose level 1
  • +3 more
  • Huntington Beach, California
  • +24 more
Jul 19, 2022

Diabetic Macula Edema Trial (Brolucizumab, Aflibercept)

Withdrawn
  • Diabetic Macula Edema
  • (no location specified)
Mar 2, 2021

Diabetic Retinopathy, Macular Edema Trial in Cleveland (aflibercept)

Completed
  • Diabetic Retinopathy
  • Macular Edema
  • aflibercept
  • Cleveland, Ohio
    Cole Eye Institute, Cleveland Clinic
Jan 25, 2021

Retinal Vein Occlusion, Diabetic Macular Edema, Branch Retinal Vein Occlusion Trial in Cleveland (Aflibercept)

Completed
Has Results
  • Retinal Vein Occlusion
  • +3 more
  • Aflibercept
  • Cleveland, Ohio
    Cole Eye Institute, Cleveland Clinic
May 10, 2021

Central Serous Chorioretinopathy, Age Related Macular Degeneration, Idiopathic Poplypoidal Choroidal Vasculopathy Trial in

Recruiting
  • Central Serous Chorioretinopathy
  • +2 more
  • aflibercept
  • Toronto, Ontario, Canada
    Sunnybrook Research Institute
Jan 25, 2021

Diabetic Macular Edema, Cataract Trial in Walnut Creek (Bevacizumab, Ranibizumab, Aflibercept)

Recruiting
  • Diabetic Macular Edema
  • Cataract
  • Walnut Creek, California
    Bay Area Retina Associates
Mar 1, 2022

Neovascular Age-Related Macular Degeneration Trial in United States (Drug: GB-102, Aflibercept)

Completed
Has Results
  • Neovascular Age-Related Macular Degeneration
  • Drug: GB-102
  • Aflibercept
  • Gilbert, Arizona
  • +32 more
Jan 10, 2022

Diabetic Macular Edema Trial in Latvia, United States (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Diabetic Macular Edema
  • Bakersfield, California
  • +45 more
Jun 2, 2022

Central Retinal Vein Occlusion Trial in Stockholm (Aflibercept, Ranibizumab)

Completed
  • Central Retinal Vein Occlusion
  • Stockholm, Sweden
    St Eriks Eye Hospital
Dec 3, 2020

Radiation Retinopathy Trial in Houston, Katy, The Woodlands (Aflibercept)

Active, not recruiting
  • Radiation Retinopathy
  • Aflibercept
  • Houston, Texas
  • +2 more
Dec 7, 2020

Retinopathy of Prematurity Trial in Worldwide (aflibercept, laser photocoagulation)

Active, not recruiting
  • Retinopathy of Prematurity
  • aflibercept
  • laser photocoagulation
  • Phoenix, Arizona
  • +51 more
Dec 20, 2021

Neovascular Age-related Macular Degeneration Trial in Shanghai (IBI302 (the first dose level), IBI302 (the second dose level),

Completed
  • Neovascular Age-related Macular Degeneration
  • IBI302 (the first dose level)
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Nov 10, 2021

Wet Age-related Macular Degeneration Trial in Puerto Rico, United States (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Wet Age-related Macular Degeneration
  • Phoenix, Arizona
  • +65 more
Jun 2, 2022

Irvine-Gass Syndrome Trial in Boston (Aflibercept)

Terminated
  • Irvine-Gass Syndrome
  • Aflibercept
  • Boston, Massachusetts
    Tufts Medical Center
Aug 19, 2020

Diabetic Macular Edema Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Diabetic Macular Edema
  • Phoenix, Arizona
  • +87 more
Jun 2, 2022

Advanced Carcinoma, NSCLC Trial in Canada, United States (Aflibercept, Pemetrexed, Cisplatin)

Terminated
Has Results
  • Advanced Carcinoma
  • Non-small Cell Lung Cancer
  • Aflibercept
  • +2 more
  • Tucson, Arizona
  • +14 more
Nov 13, 2020

Exudative Age-related Macular Degeneration Trial in United States (RBM-007 Injectable Solution, Aflibercept, Sham)

Completed
  • Exudative Age-related Macular Degeneration
  • RBM-007 Injectable Solution
  • +2 more
  • Phoenix, Arizona
  • +7 more
Feb 5, 2022

Automated Optical Coherence Tomography Image Enrichment With

Active, not recruiting
  • Neovascular Age-Related Macular Degeneration
  • Hamilton, Ontario, Canada
  • +16 more
Aug 8, 2022

Wet Macular Degeneration Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)

Terminated
  • Wet Macular Degeneration
  • Phoenix, Arizona
  • +74 more
Jun 2, 2022

Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Macular Edema
  • Retinal Vein Occlusion
  • Phoenix, Arizona
  • +140 more
Jul 20, 2022

Metastatic Colorectal Cancer Trial in Providence (Aflibercept)

Terminated
Has Results
  • Metastatic Colorectal Cancer
  • Aflibercept
  • Providence, Rhode Island
  • +1 more
Feb 13, 2020

Diabetic Macular Edema Trial in United States (Iluvien 0.19 MG Drug Implant, Aflibercept)

Recruiting
  • Diabetic Macular Edema
  • Iluvien 0.19 MG Drug Implant
  • Aflibercept
  • Phoenix, Arizona
  • +45 more
Jan 4, 2022